2026 Semifinalists

2026

President’s Innovation Challenge

Out of 400+ applications, we've selected 180+ PIC semifinalists. These ventures represent all 13 Harvard schools and are one step closer to winning a share of $500,000+ in Bertarelli Foundation funding.

pic finalist gif

An internal PIC selection committee reviews initial venture applications and selects the semifinalists.

Industry

Program

School

Clear all filters

Absco Therapeutics

AbscoTx injects image-guided therapy into tumors to educate the immune system to fight cancer locally and at metastatic sites.
Illumicell AI

Providing AI-based sperm testing for healthcare providers, enabling accurate at-home fertility assessments for patients.
Linton Lifesciences

Using 3D bioprinting to create custom arteries for bypass surgery, aiming to replace traditional autologous grafts.
NuCyRNA Therapeutics

Redefining RNA-targeting therapeutics, starting in neurodegenerative diseases.
PathCision Medicine

Developing tissue-informed precision therapeutics with superior delivery and efficacy for cancer and other complex diseases.
Promakhos Therapeutics Inc.

Developing oral, non-immunosuppressive, small molecules to cure chronic inflammatory disorders.